A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

December 13, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced CancerMetastatic CancerOvarian CancerPrimary Peritoneal CancerFallopian Tube CancerEndometrial CancerMetastatic Colorectal CancerPancreatic Ductal AdenocarcinomaAcinar Cell Carcinoma
Interventions
DRUG

ART0380

Participants will receive ART0380 by mouth either intermittently (either once daily 3 days on, 4 days off; days 2-4 and 9-11;or days 1-3 and 8-10) or continuously (once daily each day) in 21 day cycles.

DRUG

Gemcitabine

Gemcitabine was administered on Days 1 and 8 of a 21-day cycle.

DRUG

Irinotecan

Irinotecan will be administered as a 90-minute infusion on Days 1 and 8 of a 21 day cycle.

Trial Locations (71)

13057

RECRUITING

Hematology Oncology Associates of Central New York, East Syracuse

14004

RECRUITING

Hospital Universitario Reina Sofia de Córdoba, Córdoba

15006

RECRUITING

Hospital Teresa Herrera (CHUAC), A Coruña

17007

RECRUITING

Hospital Universitari Doctor Josep Trueta- ICO de Girona, Girona

19104

RECRUITING

University of Pennsylvania / Abramson Cancer Center, Philadelphia

19107

RECRUITING

Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

21044

RECRUITING

Maryland Oncology Hematology - Primary, Columbia

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

25198

RECRUITING

Hospital Arnau de Vilanova, Lleida

28007

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

28027

RECRUITING

Clínica Universidad de Navarra, Madrid

28033

RECRUITING

MD Anderson Cancer Center (Madrid, Madrid

28040

RECRUITING

Hospital Clinico San Carlos, Madrid

RECRUITING

START Madrid Fundacion Jimenez Diaz, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28046

RECRUITING

Hospital Universitario La Paz, Madrid

28050

RECRUITING

START Madrid (Hospital San Chinarro), Madrid

28223

RECRUITING

Next - Hospital Quironsalud Madrid, Pozuelo de Alarcón

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

30120

RECRUITING

Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar

31008

RECRUITING

Hospital Universitario De Navarra, Pamplona

32224

RECRUITING

Mayo Clinic (Florida), Jacksonville

32256

RECRUITING

Cancer Specialist of North Florida, Jacksonville

RECRUITING

Cancer Specialists of North Florida, Jacksonville

32827

COMPLETED

Florida Cancer Specialists, Orlando

33076

RECRUITING

Institut Bergonie, Bordeau

33401

RECRUITING

Florida Cancer Specialists, West Palm Beach

33901

RECRUITING

Florida Cancer Specialists, Fort Myers

34232

RECRUITING

Florida Cancer Specialists, Sarasota

37203

RECRUITING

SCRI Oncology Partners, Nashville

37404

RECRUITING

Tennessee Oncology, PLLC, Chattanooga

38120

COMPLETED

Baptist Cancer Center, Memphis

41009

RECRUITING

Hospital Virgen Macarena, Seville

41013

RECRUITING

Hospital Virgen del Rocío, Seville

43537

RECRUITING

Taylor Cancer Research Center, Maumee

45242

RECRUITING

Oncology Hematology Care Primary, Cincinnati

46010

RECRUITING

Incliva Biomedical Research Institute, University of Valencia, Valencia

46250

RECRUITING

Community Health Network, Indianapolis

50009

RECRUITING

Hospital Universitario Miguel Servet, Zaragoza

55369

RECRUITING

Minnesota Oncology Hematology, Maple Grove

55905

RECRUITING

Mayo Clinic (Minnesota), Rochester

60521

RECRUITING

Hope and Healing Cancer Services, Hinsdale

63110

RECRUITING

Washington University, St Louis

70808

RECRUITING

Our Lady of the Lake, Baton Rouge

72205

RECRUITING

University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock

73104

RECRUITING

Stephenson Cancer Center, Oklahoma City

75028

RECRUITING

Texas Oncology - Northeast Texas, Flower Mound

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

75246

RECRUITING

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

77030

COMPLETED

Oncology Consultants, Houston

78240

RECRUITING

Texas Oncology - San Antonio, San Antonio

78705

RECRUITING

Texas Oncology - Central/South Texas, Austin

80218

RECRUITING

Rocky Mountain Cancer Center, Denver

RECRUITING

Sarah Cannon Research Institute at HealthONE, Denver

84106

RECRUITING

Utah Cancer Specialists, Salt Lake City

85259

RECRUITING

Mayo Clinic (Arizona), Scottsdale

90033

RECRUITING

USC Norris Comprehensive Cancer Center, Los Angeles

93105

RECRUITING

Sansum Clinic, Santa Barbara

94805

RECRUITING

Institut Gustave Roussy, Villejuif

95403

RECRUITING

Providence Medical Foundation, Santa Rosa

35294-3300

RECRUITING

University of Alabama at Birmingham, Birmingham

03203

RECRUITING

Hospital General Universitario de Elche, Elche

08208

RECRUITING

H. Parc Tauli, Sabadell

08023

RECRUITING

Next Oncology Barcelona, IOB, Barcelona

08916

RECRUITING

Institut Català d'Oncologia Badalona - Hospital Germans Trias i Pujol, Badalona

08035

RECRUITING

Vall d'Hebron Institute of Oncology (VIHO), Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08903

RECRUITING

ICO Hospitalet, Barcelona

SE1 9RT

RECRUITING

Guy's and St Thomas' NHS Foundation Trust, London

G12 0YN

RECRUITING

Beatson West of Scotland Cancer Centre, Glasgow

W1G 6AD

RECRUITING

Sarah Cannon Research Institute UK, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Artios Pharma Ltd

INDUSTRY

NCT04657068 - A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter